Pancreatic Cancer Research

ResearcherLyon 1 UniversitéNo recent work listed

Philippe Bouvet

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4524-2233; OpenAlex author ID A5014995390. Sources: OpenAlex.

Their work

Papers
5 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
12
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 2 papers · 2022: 2 papers

Papers 5

  1. Nucleolin Therapeutic Targeting Decreases Pancreatic Cancer Immunosuppression. Co-author DOI 10.3390/cancers14174265↗
  2. Correction: Ponzo et al. Nucleolin Therapeutic Targeting Decreases Pancreatic Cancer Immunosuppression. Cancers 2022, 14, 4265. Co-author DOI 10.3390/cancers14246160↗
  3. Nucleolin Targeting by N6L Inhibits Wnt/β-Catenin Pathway Activation in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/cancers13122986↗
  4. Nucleolin Aptamer N6L Reprograms the Translational Machinery and Acts Synergistically with mTORi to Inhibit Pancreatic Cancer Proliferation. Last author DOI 10.3390/cancers13194957↗
  5. Nucleolin Targeting Impairs the Progression of Pancreatic Cancer and Promotes the Normalization of Tumor Vasculature. Co-author DOI 10.1158/0008-5472.can-16-0300↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ilaria Cascone · 5 shared papers, 2016–2022 · strength 0.53
  2. Mounira Chalabi‐Dchar · 4 shared papers, 2021–2022 · strength 0.49
  3. Anaïs Debesset · 3 shared papers, 2021–2022 · strength 0.34
  4. Matteo Ponzo · 3 shared papers, 2021–2022 · strength 0.34
  5. José Laurent Cohen · 3 shared papers, 2021–2022 · strength 0.34
  6. Fabio Raineri · 3 shared papers, 2021–2022 · strength 0.34
  7. Rémy Nicolle · 2 shared papers, 2022 · strength 0.23
  8. Corinne Bousquet · 2 shared papers, 2022 · strength 0.23
  9. Christophe Tournigand · 2 shared papers, 2022 · strength 0.23
  10. Anne Couvelard Benveniste · 2 shared papers, 2016–2021 · strength 0.15
  11. Jerome F. Cros · 1 shared paper, 2021 · strength 0.11
  12. Maud-Emmanuelle Gilles · 1 shared paper, 2016 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.